Hesperetin Inhibits Vascular Formation by Suppressing of the PI3K/AKT, ERK, and p38 MAPK Signaling Pathways
Author:
Open Access
- 31 December 2014
- journal article
- Published by The Korean Society of Food Science and Nutrition in Preventive Nutrition and Food Science
- Vol. 19 (4) , 299-306
Abstract
Hesperetin has been shown to possess a potential anti-angiogenic effect, including vascular formation by endothelial cells. However, the mechanisms underlying the potential anti-angiogenic activity of hesperetin are not fully understood. In the present study, we evaluated whether hesperetin has anti-angiogenic effects in human umbilical vascular endothelial cells (HUVECs). HUVECs were treated with 50 ng/mL vascular endothelial growth factor (VEGF) to induce proliferation as well as vascular formation, followed by treatment with several doses of hesperetin (25, 50, and 100 μM) for 24 h. Cell proliferation and vascular formation were analyzed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and tube formation assay, respectively. In addition, cell signaling related to cell proliferation and vascular formation was analyzed by western blot. Furthermore, a mouse aorta ring assay was performed to confirm the effect of hesperetin on vascular formation. Hesperetin treatment did not cause differences in HUVECs proliferation. However, hesperetin significantly inhibited VEGF-induced cell migration and tube formation of HUVECs (P<0.05). Moreover, hesperetin suppressed the expression of ERK, p38 MAPK, and PI3K/AKT in the VEGF-induced HUVECs. In an ex vivo model, hesperetin also suppressed microvessel sprouting of mouse aortic rings. Taken together, the findings suggest that hesperetin inhibited vascular formation by endothelial cells via the inhibition of the PI3K/AKT, ERK and p38 MAPK signaling.Keywords
This publication has 35 references indexed in Scilit:
- Use of the mouse aortic ring assay to study angiogenesisNature Protocols, 2011
- Molecular mechanisms and clinical applications of angiogenesisNature, 2011
- Differentiation of endothelial cells derived from mouse embryoid bodies: A possible in vitro vasculogenesis modelToxicology Letters, 2008
- Gambogic Acid Inhibits Angiogenesis and Prostate Tumor Growth by Suppressing Vascular Endothelial Growth Factor Receptor 2 SignalingCancer Research, 2008
- Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cellsCardiovascular Research, 2006
- Further investigation of the modifying effect of various chemopreventive agents on apoptosis and cell proliferation in human colon cancer cellsJournal of Cancer Research and Clinical Oncology, 2002
- ‘Angioprevention’: angiogenesis is a common and key target for cancer chemopreventive agentsThe FASEB Journal, 2002
- Endostatin Inhibits Microvessel Formation in the ex Vivo Rat Aortic Ring Angiogenesis AssayBiochemical and Biophysical Research Communications, 2000
- The Hallmarks of CancerCell, 2000
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI: Journal of the National Cancer Institute, 1990